Molecular HydroGEN Investment Group, part of the H2 Global Group, has joined forces with VR LIFE. It invested CZK 15 million in the company, which uses virtual reality in healthcare through its VR Vitalis product, and bought a 20% stake. This follows the introduction of the unique combination of the regenerative effects of Molecular Hydrogen and virtual reality and the registration of a joint patent and utility model for this therapy.

Inhalation of molecular hydrogen improves the physical fitness of patients with rheumatic diseases. This is the result of a study that took place for almost 2 years at the Teplice nad Bečvou Spa, which involved experts from Palacký University in Olomouc.

A unique study has commenced at Bludov Spa, investigating the impact of molecular hydrogen on weight loss in obese children. This innovative approach, conducted in collaboration with the Faculty of Physical Culture at Palacký University and H2 Global Group, has the potential to revolutionise obesity treatment among adolescents. The research is being carried out as a double-blind experiment to ensure objective results. Obesity affects approximately 20% of the Czech population and over 13% of people worldwide, making it a pressing global health issue.